# Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ Failure

> **NCT04123444** · PHASE2,PHASE3 · COMPLETED · sponsor: **Jakob Stensballe, MD, PhD** · enrollment: 279 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Iloprost
- **DRUG:** Isotonic saline

## Key facts

- **NCT ID:** NCT04123444
- **Lead sponsor:** Jakob Stensballe, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-30
- **Primary completion:** 2022-06-28
- **Final completion:** 2022-06-28
- **Target enrollment:** 279 (ACTUAL)
- **Last updated:** 2024-05-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04123444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04123444, "Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ Failure". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04123444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*